TY  - CHAP
M1  - Book, Section
TI  - LYSERGIC ACID DIETHYLAMIDE (LSD) AND OTHER HALLUCINOGENS
A1  - Armenian, Patil
A2  - Olson, Kent R.
A2  - Anderson, Ilene B.
A2  - Benowitz, Neal L.
A2  - Blanc, Paul D.
A2  - Clark, Richard F.
A2  - Kearney, Thomas E.
A2  - Kim-Katz, Susan Y.
A2  - Wu, Alan H. B.
PY  - 2018
T2  - Poisoning & Drug Overdose, 7e
AB  - Patients  who  seek  medical  care  after  self-administering  mind-altering  substances  may  have  used  any  of  a  large  variety  of  compounds.  Several  of  these  agents  are  discussed  elsewhere  in  this  manual  (eg,  amphetamines,  cocaine,  marijuana,  phencyclidine  and  ketamine,  and  toluene).  Many  of  the  drugs  discussed  in  this  chapter  are  entactogens  ("to  touch  within"),  enhancing  sensations  and  promoting  illusions  (eg,  LSD,  MDMA).  Others  have  primarily  sympathomimetic  characteristics,  with  hallucinations  a  smaller  part  of  the  overall  experience  (eg,  cathinones,  PMA).  Several  have  been  used  widely  for  personal  experimentation  as  well  as  clinically  to  facilitate  psychotherapy.  Although  the  use  of  traditional  hallucinogens  such  as  LSD  has  declined  over  the  past  decades,  there  is  a  current  resurgence  of  hallucinogen  use  from  novel  compounds,  such  as  the  2C-NBOMe  series  and  synthetic  cathinones.  Table  II–35  lists  some  common  and  uncommon  hallucinogens.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1179991809
ER  -